Truist upgraded pain therapy developer Pacira BioSciences (NASDAQ:PCRX) to Hold from Sell on Thursday, noting that the ...

Truist Securities adjusted its outlook on Manpower Inc . (NYSE:MAN), reducing the staffing company's price target from $74.00 to $70.00. Despite this change, the firm maintained its Hold rating on the ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...

Influence Media Partners (“Influence Media” or “Influence”) — a leading music and entertainment company focused on partnering with and investing in to ...

Net interest margin, which measures lending profitability, expanded to 3.07%, compared with 2.95% a year earlier. Truist's ...

Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...

Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of Sysco Corp (NYSE:SYY) and lowered the price ...

Truist Financial analyst Youssef Squali maintained a Buy rating on Cimpress (CMPR – Research Report) today. The company’s shares closed ...

This was the stock's second consecutive day of gains.

Truist initiated coverage of Tronox (TROX) with a Buy rating and $17 price target The firm believes Tronox has one of the “strongest ...